Fever News and Research

RSS

WHO: Single dose of vaccination sufficient to confer life-long immunity against yellow fever disease

The yellow fever 'booster' vaccination given ten years after the initial vaccination is not necessary, according to WHO.

17 May 2013

Galapagos, AbbVie announce extension of GLPG0634 clinical development collaboration

Galapagos NV and AbbVie announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3.

17 May 2013

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found.

17 May 2013

Research findings have implications for understanding how to slow spread of dengue virus

Researchers have identified the dose of dengue virus in human blood that is required to infect mosquitoes when they bite. Mosquitoes are essential for transmitting the virus between people so the findings have important implications for understanding how to slow the spread of the disease.

14 May 2013

New study provides clear picture of the impact and causes of diarrheal diseases

A new international study published today in The Lancet provides the clearest picture yet of the impact and most common causes of diarrheal diseases, the second leading killer of young children globally, after pneumonia.

14 May 2013

COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

Study shows malaria transmission can be controlled by using bacteria

Mosquitoes are deadly efficient disease transmitters. Research conducted at Michigan State University, however, demonstrates that they also can be equally adept in curing diseases such as malaria.

10 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Discovery raises hope for severe forms of human epilepsy

Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.

5 May 2013

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

4 May 2013

Study identifies the vector that transmitted malaria from apes to humans

In 2010, a study revealed that the main agent of malaria in humans, called Plasmodium falciparum, arose from the gorilla. Today, the vector which transmitted the parasite from apes to humans has just been identified.

3 May 2013

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Prenoxad Injection, the world's first licensed emergency treatment for acute opioid related overdose for use at home or other non-medical settings.

3 May 2013

New approach could democratize viral surveillance, says UCSF scientist

The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to new research led by scientists at UC San Francisco.

3 May 2013

H7N9 bird flu virus continues to spread throughout China

"China on Saturday reported its first case of H7N9 bird flu in the southern province of Hunan, the latest sign the virus that has killed 23 people in the country is continuing to spread," Reuters reports (Ruwitch, 4/29).

30 Apr 2013

Collaborative research network to understand spread of infectious diseases

The Models of Infectious Disease Agent Study is a collaborative research network funded by the National Institutes of Health that uses computational, statistical and mathematical models to understand the spread of infectious diseases such as influenza, pertussis, West Nile disease, dengue fever and cholera.

30 Apr 2013

Children born outside U.S. have lower prevalence of allergic disease

A study by Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of St. Luke's—Roosevelt Hospital Center, New York, and colleagues suggests children living the in the United States but born outside the U.S. have a lower prevalence of allergic disease that increases after residing in the United States for one decade.

30 Apr 2013

Fever News and Research

WHO: Single dose of vaccination sufficient to confer life-long immunity against yellow fever disease

Galapagos, AbbVie announce extension of GLPG0634 clinical development collaboration

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Research findings have implications for understanding how to slow spread of dengue virus

New study provides clear picture of the impact and causes of diarrheal diseases

COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Study shows malaria transmission can be controlled by using bacteria

UA researchers discover genetic mutations that cause severe epilepsies in children

Discovery raises hope for severe forms of human epilepsy

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Study identifies the vector that transmitted malaria from apes to humans

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

New approach could democratize viral surveillance, says UCSF scientist

H7N9 bird flu virus continues to spread throughout China

Collaborative research network to understand spread of infectious diseases

Children born outside U.S. have lower prevalence of allergic disease

Forecasting outbreak of dengue fever with warning system

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Antihistamine drugs work by preventing histamine from attaching to H1 receptors

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News